Clinical trial
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
NCT00001529 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Recruiting
Key facts
| NCT number | NCT00001529 |
|---|---|
| Title | Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives |
| Official title | Use of Granulocyte Colony Stimulating Factor (G-CSF) Mobilized Leukapheresis Collections From Healthy Volunteers to Develop Improved Methods of Stem Cell and Lymphocyte Selection for Allogeneic Transplantation |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | New York University and New York Genome Center |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Graft-Versus-Host Disease, Graft-versus-leukemia, Donor Apheresis |
| Intervention type | Drug |
| Interventions | G-CSF |
| Enrollment | 500 |
| Start date | Mar 18, 1996 |
| First posted | Nov 4, 1999 |
| Last update posted | Jan 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: